Home Discriminant value of % microcytic/% hypochromic ratio in the differential diagnosis of microcytic anemia
Article
Licensed
Unlicensed Requires Authentication

Discriminant value of % microcytic/% hypochromic ratio in the differential diagnosis of microcytic anemia

  • Eloísa Urrechaga
Published/Copyright: December 1, 2008

Abstract

Background: % Microcytic and % hypochromic red cells show an inverse trend in β thalassemia trait and in iron deficiency anemia (IDA). The aim of this study was to assess the discriminant value of % microcytic/% hypochromic ratio, as can be obtained from the Advia 2120 (Siemens) analyzer, in the differential diagnosis of microcytic anemia, compared to the conventional England and Fraser, Green and King, Mentzer, Ricerca, Shine and Lal and Srivastava indices.

Methods: Receiver operating characteristic (ROC) curves, sensitivity, specificity and Youden index of indices were calculated for a set of 148 IDA patients and 170 β thalassemia carriers.

Results: The Green and King index showed the best area under the curve (AUC, 0.962), with a Youden index of 80.9%; the % microcytic/% hypochromic ratio ranked second (AUC 0.943), with a Youden index of 76.3% and a sensitivity of 99.2%.

Conclusions: This index, with high sensitivity for β thalassemia screening, can be a useful tool in the differential diagnosis of microcytic anemia, so samples can be chosen for HbA2 analysis, to confirm the presumptive diagnosis of the disease. As specificity is 77.1%, we assume it will be 22.9% for false positives, but these samples will have HbA2 values within the reference range, for correct diagnosis.

Clin Chem Lab Med 2008;46:1752–8.


Corresponding author: Dr. Eloísa Urrechaga, Hematology Laboratory, Hospital Galdakao-Usansolo, 48960 Galdakao, Vizcaya, Spain Phone: +34-94-400-7102, Fax: +34-94-400-7128,

Received: 2008-6-6
Accepted: 2008-8-28
Published Online: 2008-12-01
Published in Print: 2008-12-01

©2008 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editors' and Publisher's Note
  2. CCLM Award for the most cited paper recently published
  3. Reviews
  4. Cystatin C: current position and future prospects
  5. Some heterogeneity factors affecting the B-type natriuretic peptides outcome: a meta-analysis
  6. Genetics and Molecular Diagnostics
  7. Effect of cyclin D1 (CCND1) polymorphism on gastric premalignant condition
  8. Identification of two de novo mutations in Chinese patients with X-linked adrenoleukodystrophy
  9. CYP21A2 gene mutation analysis in Moroccan patients with classic form of 21-hydroxylase deficiency: high regional prevalence of p.Q318X mutation and identification of a novel p.L353R mutation
  10. Apolipoprotein A5 gene −1131T/C polymorphism is associated with the risk of metabolic syndrome in ethnic Chinese in Taiwan
  11. Association of GSTM1 and GSTT1 gene polymorphisms with coronary artery disease in relation to tobacco smoking
  12. Use of the biochip microarray system in detection of myocardial injury caused by radiofrequency catheter ablation
  13. An in-house method for the detection and quantification of HCV in serum samples using a TaqMan assay real time PCR approach
  14. General Clinical Chemistry and Laboratory Medicine
  15. Drugs and brain death diagnostics: determination of drugs capable of inducing EEG zero line
  16. Accurate assessment and identification of naturally occurring cellular cobalamins
  17. Development and validation of a high-performance liquid chromatography assay for posaconazole utilizing solid-phase extraction
  18. Discriminant value of % microcytic/% hypochromic ratio in the differential diagnosis of microcytic anemia
  19. Determination of carbohydrate-deficient transferrin (CDT) in Italy
  20. Validation and Outcome Studies
  21. Critical evaluation of connectivity-based point of care testing systems of glucose in a hospital environment
  22. Validation of a novel ELISA for measurement of electronegative low-density lipoprotein
  23. Five commercially available insulin-like growth factor I (IGF-I) assays in comparison to the former Nichols Advantage IGF-I in a growth hormone treated population
  24. Introduction of non-linearity by data transformation in method comparison and commutability studies
  25. Reliability and correlation study of a new homocysteine assay
  26. Letters to the Editor
  27. Prevention of preanalytical false-positive increases of cardiac troponin I on the Unicel® DxI 800 analyzer
  28. Does carbamylated hemoglobin still affect the analysis of HbA1c in uremic and hyperglycemic patients?
  29. Recombinant immunoblot for assessment of intrathecally synthesised paraneoplastic antineuronal antibodies in cerebrospinal fluid from patients with paraneoplastic neurological syndromes
  30. Detection of duplicates and redundancies. A major responsibility of peer-reviewers?
  31. Erratum
  32. Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome
  33. Acknowledgement
  34. Acknowledgements
  35. Contents
  36. Contents, Volume 46, 2008
  37. Author Index
  38. Author Index
  39. Subject Index
  40. Subject Index
Downloaded on 12.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2008.355/html
Scroll to top button